Affordable and accessible medicines for the entire world

Trek Therapeutics is a for-profit company, organized as a public benefit corporation.  Its mission is to develop medicines to treat infectious diseases and commercialize them for global populations. The company’s founders have collectively participated in developing seven approved antiviral drugs. Our objective is to profitably develop safe, novel medicines for infectious diseases at affordable and accessible prices.

Latest News: Trek/Ambrosus Blockchain Partnership
–  Oct 2017: Securing the Cold Chain with New Solutions
–  Aug 2017: Ambrosus/Trek Agreement for Blockchain Protocol